Pre-open movers
U.S. stock futures traded lower in early pre-market trade. Data on factory orders for February will be released at 10:00 a.m.
ET.
Futures for the Dow Jones Industrial Average fell 72 points to 26,322.00, while the Standard & Poor’s 500 index futures declined
3 point to 2,893.00. Futures for the Nasdaq 100 index dropped 7.5 points to 7,596.75.
Oil prices traded higher as Brent crude futures rose
0.5 percent to trade at $70.68 per barrel, while US WTI crude futures gained 0.4 percent to trade at $63.36 a barrel.
A Peek Into Global Markets
European markets were mostly higher today, with the Spanish Ibex Index falling 0.5 percent, STOXX Europe 600 Index gaining 0.1
percent and German DAX 30 index slipped 0.2 percent. The UK's FTSE index was trading higher by 0.1 percent, while French CAC 40
Index rose 0.2 percent.
In Asian markets, Japan’s Nikkei Stock Average fell 0.21 percent, Hong Kong’s Hang Seng Index climbed 0.47 percent, China’s
Shanghai Composite Index fell 0.05 percent and India’s BSE Sensex fell 0.42 percent.
Broker Recommendation
Analysts at UBS downgraded Starbucks Corporation (NASDAQ: SBUX) from Buy to Neutral and raised the price target from $72 to $78.
Starbucks shares fell 1.2 percent to $74.15 in pre-market trading.
Breaking News
-
Uniqure NV (NASDAQ: QURE) reported
that it has received FDA Fast Track designation for AMT-130 gene therapy for the treatment of Huntington's disease.
-
2U Inc (NASDAQ: TWOU) announced plans
to buy Trilogy Education for $750 million in cash and stock.
-
Versum Materials Inc (NYSE: VSM)
disclosed that it has received revised takeover proposal from Merck KGaA, from $48 per share to $53 per share in cash.
-
United Therapeutics Corporation (NASDAQ: UTHR) disclosed that its BEAT study of esuberaprost did not meet primary
endpoint.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.